本研究针对重复前列腺活检中PI-RADS 3病变的诊断挑战，通过回顾性分析684例患者数据，发现PI-RADS 3是阴性活检的独立预测因子（OR 0.582），而PSA密度（PSAD）在PI-RADS 4-5病变中具有显著风险分层价值（62.4% vs 33.8%），在PI-RADS 3中则差异有限（20.7% vs 16.2%）。该研究为 ...

本研究针对基于白人群体开发的PI-RADS评分系统在非白人群体中的适用性问题，通过分析PREVENT试验中665例PI-RADS 3-5分患者的活检数据，发现黑人男性PI-RADS 3分病灶的临床显著前列腺癌(csPCa)检出率较白人高20%(OR 1.20, P=0.004)，而亚洲男性PI-RADS 3分病灶均未检出癌症。

Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer. Prostate cancer (PCa) in 696 hypogonadal men with and without long-term testosterone therapy (TTh): ...

PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...

Patterns of failure after radiotherapy (RT) in patients with prostate cancer re-staged with 18F-DCFPyL PSMA-PET: A regional cohort analysis.